5543Risk assessment tool to inform mitigation measures for international travel in the context of COVID-19: annex to: Considerations for implementing a risk-based approach to international travel in the context of COVID-19, 16 December 2020Technical Documents · 16 декабря 2020 г.
5544Therapeutics and COVID-19: living guideline, 17 December 2020Technical Documents · 16 декабря 2020 г.
5546Considerations for implementing a risk-based approach to international travel in the context of COVID-19: interim guidance, 16 December 2020Technical Documents · 16 декабря 2020 г.
5547WHO COVID-19: case definitions: updated in public health surveillance for COVID-19, published 16 December 2020Technical Documents · 16 декабря 2020 г.
5548Measles and rubella elimination country profile: SloveniaTechnical Documents · 16 декабря 2020 г.
5551Measles and rubella elimination country profile: Czech RepublicTechnical Documents · 15 декабря 2020 г.
5553The effects of COVID-19 in people living with diabetes – based on information as at 31 October 2020Technical Documents · 15 декабря 2020 г.
5554Measles and rubella elimination country profile: AzerbaijanTechnical Documents · 15 декабря 2020 г.
5556Efeitos da COVID-19 nos cuidados para o VIH – com base na informação disponível em 12 de Novembro de 2020Technical Documents · 15 декабря 2020 г.
5557Health impact assessment of air pollution: introductory manual to AirQ+Technical Documents · 15 декабря 2020 г.
5559EVIPNet Europe annual report 2019: towards a world in which the best available research evidence informs policy-makingTechnical Documents · 15 декабря 2020 г.